HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Nishikawa Selected Research

Satoshi Nishikawa Research Topics

Disease

4Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2020 - 01/2005
3Inflammation (Inflammations)
01/2019 - 11/2002
3Bone Resorption
05/2016 - 12/2011
2Osteoporosis
07/2019 - 08/2014
2Experimental Arthritis
01/2019 - 01/2016
2Leukemia
12/2014 - 05/2014
2Pancreatitis
11/2002 - 11/2002
2Ischemia
11/2002 - 11/2002
1Aneuploidy (Aneuploid)
03/2021
1Rheumatoid Arthritis
01/2019
1Hypothyroidism
01/2013
1Bovine Spongiform Encephalopathy (Mad Cow Disease)
01/2013
1Fibrosis (Cirrhosis)
12/2011
1Metabolic Bone Diseases (Osteopenia)
12/2011
1Myocardial Infarction
08/2007
1Infarction (Infarctions)
08/2007
1Virus Diseases (Viral Diseases)
10/2005
1Neoplasms (Cancer)
04/2004
1Airway Obstruction (Choking)
12/2003
1Hemorrhage
12/2003
1Dyspnea (Shortness of Breath)
12/2003
1Neoplasm Metastasis (Metastasis)
12/2003
1Rectal Neoplasms (Rectal Cancer)
12/2003
1Sigmoid Neoplasms
12/2003
1Colorectal Neoplasms (Colorectal Cancer)
12/2003
1Pulmonary Atelectasis
12/2003
1Hemoptysis
12/2003
1Hepatitis D
12/2002
1Necrosis
11/2002
1Edema (Dropsy)
11/2002
1Hyperamylasemia
11/2002
1Proteinuria
08/2002
1Glomerulonephritis
08/2002

Drug/Important Bio-Agent (IBA)

5ONO-5334IBA
07/2019 - 12/2011
3Prion ProteinsIBA
01/2020 - 01/2005
3Cathepsin KIBA
01/2019 - 12/2011
3Adenosine (Adenocard)FDA LinkGeneric
11/2002 - 08/2002
3QuinazolinonesIBA
11/2002 - 08/2002
33- (1- (6,7- diethoxy- 2- morpholinoquinazolin- 4- yl)piperidin- 4- yl)- 1,6- dimethyl- 2,4- (1H,3H)- quinazolinedioneIBA
11/2002 - 08/2002
1Proteins (Proteins, Gene)FDA Link
03/2021
1Protein Isoforms (Isoforms)IBA
01/2020
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1salicylhydroxamic acid (SHAM)IBA
05/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Thrombopoietin (c-mpl Ligand)IBA
12/2014
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
12/2014
13-deazaneplanocinIBA
05/2014
1Histone MethyltransferasesIBA
05/2014
1Small Interfering RNA (siRNA)IBA
05/2014
1R12 RNA aptamerIBA
01/2013
1XenobioticsIBA
01/2013
1Nucleotide AptamersIBA
01/2013
1Diphosphonates (Bisphosphonates)IBA
12/2011
1Alendronate (Alendronate Sodium)FDA LinkGeneric
12/2011
1collagen type I trimeric cross-linked peptideIBA
12/2011
1Collagen Type I (Type I Collagen)IBA
12/2011
1APTIBA
04/2008
1technetium tc-99m tetrofosmin (Myoview)FDA Link
08/2007
1RNA (Ribonucleic Acid)IBA
10/2005
1CatalaseIBA
04/2004
1N- beta- alanyl- 5- S- glutathionyl- 3,4- dihydroxyphenylalanineIBA
04/2004
1Fluorouracil (Carac)FDA LinkGeneric
12/2003
1Catalytic RNA (Ribozymes)IBA
12/2002
1AmylasesFDA Link
11/2002
1Purinergic P1 Receptor AntagonistsIBA
11/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2002
1EthionineIBA
11/2002
18-(4-sulfophenyl)theophyllineIBA
11/2002
1CeruletideIBA
11/2002
1Choline (Choline Chloride)IBA
11/2002
1Lipase (Acid Lipase)FDA Link
11/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2002
1Prednisolone (Predate)FDA LinkGeneric
08/2002

Therapy/Procedure

2Cell- and Tissue-Based Therapy (Cell Therapy)
03/2021 - 08/2007
2Drug Therapy (Chemotherapy)
05/2014 - 12/2003
2Intravenous Injections
11/2002 - 08/2002
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2014
1Therapeutics
12/2011
1Transplantation
08/2007
1Intraperitoneal Injections
11/2002